Skip to main content
. Author manuscript; available in PMC: 2017 Sep 5.
Published in final edited form as: Discov Med. 2017 Mar;23(126):189–199.

Table 2.

Summary of ENKTL Cell Lines.

Cell Line Patient Source Cell Lineage
NKYS 19 year old female from Japan NK-cell, εCD3+, CD56+
SNK6 62 year old, nasal tumor from Japan NK-cell, εCD3+, CD56+
NK92 50 year old non-nasal tumor from Caucasian NK-cell, εCD3+, CD56+
SNK1 24 year old from Japan NK-cell, εCD3+, CD56+
SNT8 48 year old, nasal tumor from Japan γδT-cell, CD3+, CD56+
NK-S1 Xenograft of nasal tumor from China (Loong et al. Leuk & Lymphoma, 2008) εCD3+, TIA-1+, CD56-